Yuehui Yin

机构：Dalian Medical University, Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University · ORCID：0000-0001-9769-435X

发表论文 184 篇 · 总被引 3351 次 · h-index 32

代表论文

• Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial (2025 · The Lancet · 被引 77)
• Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials (2025 · The Lancet · 被引 39)
• Efficacy and safety of sympathetic mapping and ablation of renal nerves for the treatment of hypertension (SMART): 6-month follow-up of a randomised, controlled trial (2024 · EClinicalMedicine · 被引 26)
• Comprehensive analysis of VEGF/VEGFR inhibitor-induced immune-mediated hypertension: integrating pharmacovigilance, clinical data, and preclinical models (2024 · Frontiers in Immunology · 被引 18)
• Sodium Glucose Transporter 2 Inhibitor Protects Against Heart Failure With Preserved Ejection Fraction: Preclinical “2‐Hit” Model Reveals Autophagy Enhancement Via AMP‐Activated Protein Kinase/Mammalian Target of Rapamycin Complex 1 Pathway (2025 · Journal of the American Heart Association · 被引 12)
• Relationship between serum uric acid levels and uric acid lowering therapy with the prognosis of patients with heart failure with preserved ejection fraction: a meta-analysis (2024 · Frontiers in Cardiovascular Medicine · 被引 8)